Cargando...
Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease
BACKGROUND: Prostate-specific antigen (PSA) screening for prostate cancer results in a large number of unnecessary prostate biopsies. There is a need for specific molecular markers that can be used in combination with PSA to improve the specificity of PSA screening. We examined GADD45a methylation i...
Gardado en:
| Publicado en: | Br J Cancer |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Nature Publishing Group
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4522641/ https://ncbi.nlm.nih.gov/pubmed/26171936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.240 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|